A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30mg and ibuprofen 2400mg for the treatment of patients with osteoarthritis

Slides:

Advertisements

Similar presentations

Efficacy of ultrasound therapy for the management of knee osteoarthritis: a systematic review with meta-analysis A. Loyola-Sánchez, J. Richardson, N.J.

Advertisements

Comparative effectiveness of alternative clinical pathways for primary hip and knee joint replacement patients: a pragmatic randomized, controlled trial

NASHA hyaluronic acid vs methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial R. Leighton, C. Åkermark,

Understanding the pain experience in hip and knee osteoarthritis – an OARSI/OMERACT initiative G.A. Hawker, M.D., M.Sc., L. Stewart, M.Sc., M.R. French,

Short-term placebo response in trials of patients with symptomatic osteoarthritis: differences between hip and knee S. Reiter-Niesert, M. Boers, J. Detert

Efficacy of patient education and supervised exercise vs patient education alone in patients with hip osteoarthritis: a single blind randomized clinical.

The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee.

Dr L. S. Kim, N. D. , Dr L. J. Axelrod, N. D. , Dr P. Howard, M. D

Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study

Disability and quality of life of patients with knee or hip osteoarthritis in the primary care setting and factors associated with general practitioners'

A. W. A. Baltzer, M. D. , C. Moser, M. D. , S. A. Jansen, M. D. , R

Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study

Influence of flare design on symptomatic efficacy of non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis of randomized placebo-controlled.

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized,

Associations between pre-operative radiographic changes and outcomes after total knee joint replacement for osteoarthritis M.M. Dowsey, M. Nikpour, P.

Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee Najib.

Avoidance of activity and limitations in activities in patients with osteoarthritis of the hip or knee: a 5 year follow-up study on the mediating role.

Responsiveness and clinically important differences for the WOMAC and SF-36 after hip joint replacement J.M. Quintana, Ph.D., A. Escobar, M.D., A. Bilbao,

Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline E. Qvistgaard, M.D., R. Christensen,

Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans Mark.

P.S. McCabe, N. Maricar, M.J. Parkes, D.T. Felson, T.W. O'Neill

Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement A. Escobar, M.D., J.M. Quintana, Ph.D., A. Bilbao,

A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid,

Pre-operative interventions (non-surgical and non-pharmacological) for patients with hip or knee osteoarthritis awaiting joint replacement surgery – a.

Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and/or knee: a randomised trial

Colchicine lack of effectiveness in symptom and inflammation modification in knee osteoarthritis (COLKOA): a randomized controlled trial Y.Y. Leung,

Measuring and realizing the translational significance of preclinical in vivo studies of painful osteoarthritis M. Hummel, G.T. Whiteside Osteoarthritis.

Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review J.C. Fernández López, M.D., Ph.D.,

Brace treatment for osteoarthritis of the knee: a prospective randomized multi-centre trial R.W. Brouwer, M.D., T.M. van Raaij, M.D., J.A.N. Verhaar,

B. Slatkowsky-Christensen, M. D. , T. K. Kvien, M. D. , Ph. D. , N

A 3-month, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a highly optimized, capacitively coupled, pulsed.

Comparative effectiveness of alternative clinical pathways for primary hip and knee joint replacement patients: a pragmatic randomized, controlled trial

Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results.

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized,

Randomized double-blind crossover study of the efficacy of a tart cherry juice blend in treatment of osteoarthritis (OA) of the knee H.R. Schumacher,

Efficacy of combined local mechanical vibrations, continuous passive motion and thermotherapy in the management of osteoarthritis of the knee G.S. Kitay,

J. Avouac, M.D., L. Gossec, M.D., M. Dougados, M.D.

OA phenotypes, rather than disease stage, drive structural progression – identification of structural progressors from 2 phase III randomized clinical.

J. Ranstam Osteoarthritis and Cartilage

A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee

Knee arthroscopic surgery is beneficial to middle-aged patients with meniscal symptoms: a prospective, randomised, single-blinded study H. Gauffin, S.

Effectiveness of thermal and athermal short-wave diathermy for the management of knee osteoarthritis: a systematic review and meta-analysis Y. Laufer,

Assessment of joint space narrowing with conventional standing antero-posterior radiographs: relief in mild-to-moderate pain is not a confounder in recent.

Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study G.

Efficacy of low frequency pulsed subsensory threshold electrical stimulation vs placebo on pain and physical function in people with knee osteoarthritis:

The course of limitations in activities over 5 years in patients with knee and hip osteoarthritis with moderate functional limitations: risk factors for.

Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous.

Osteoarthritis of the knee after meniscal resection: long term radiographic evaluation of disease progression P.T. Paradowski, L.S. Lohmander, M. Englund

Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing.

Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials E.M. Bartels, V.N. Folmer, H. Bliddal,

Long-term effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a randomized controlled trial comparing two different.

D.J. Hunter Osteoarthritis and Cartilage

A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee T.J. Schnitzer, J.A. Marks Osteoarthritis.

D.J. Hunter Osteoarthritis and Cartilage

C. Ratzlaff, M. Koehoorn, J. Cibere, J. Kopec

T. Silvestri, M. D. , L. Pulsatelli, Ph. D. , P. Dolzani, Ph. D. , A

Development and preliminary evaluation of the OsteoArthritis Questionnaire (OA- Quest): a psychometric study L. Busija, R. Buchbinder, R.H. Osborne Osteoarthritis.

Osteoarthritis year 2012 in review: biology

Measurement of structure (disease) modification in osteoarthritis

The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled.

Efficacy of rehabilitation programs for improving muscle strength in people with hip or knee osteoarthritis: a systematic review with meta-analysis A.

T. Schäfer, F. Krummenauer, J. Mettelsiefen, S. Kirschner, K. P

Patient education with or without manual therapy compared to a control group in patients with osteoarthritis of the hip. A proof-of-principle three-arm.

Manual therapy, exercise therapy, or both, in addition to usual care, for osteoarthritis of the hip or knee: a randomized controlled trial. 1: clinical.

Changes in pain, stiffness and physical function in patients with osteoarthritis waiting for hip or knee joint replacement surgery H. Kapstad, R.N.,

Symptomatic efficacy of avocado–soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials R. Christensen,

M. Doherty, P. Dieppe Osteoarthritis and Cartilage

A randomised controlled trial of tidal irrigation vs corticosteroid injection in knee osteoarthritis: the KIVIS Study N.K. Arden, M.D., I.C. Reading,

Osteoarthritis and Cartilage

A new lipid formulation of low dose ibuprofen shows non-inferiority to high dose standard ibuprofen: the FLARE study (flaring arthralgia relief evaluation.

Presentation transcript:

A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30mg and ibuprofen 2400mg for the treatment of patients with osteoarthritis A. Puopolo, M.D., J.A. Boice, Ph.D., J.L. Fidelholtz, M.D., T.W. Littlejohn, M.D., P. Miranda, M.D., A. Berrocal, M.D., A. Ko, M.P.H., N. Cichanowitz, M.S.J., A.S. Reicin, M.D. Osteoarthritis and Cartilage Volume 15, Issue 12, Pages 1348-1356 (December 2007) DOI: 10.1016/j.joca.2007.05.022 Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 1 Disposition of patients with OA enrolled in 12-week evaluation of etoricoxib 30mg and ibuprofen 2400mg vs placebo. †: The most common reasons patients were not randomized were due to failure to meet one or more inclusion criteria (i.e., not satisfying flare criteria and having a clinical diagnosis of OA based on clinical and radiographic criteria) or because one or more exclusion criteria were met (i.e., having an abnormal laboratory safety test result). ‡: Other reasons for discontinuation included lost to follow-up; unknown reason; patient moved; patient withdrew consent; and protocol deviation. Osteoarthritis and Cartilage 2007 15, 1348-1356DOI: (10.1016/j.joca.2007.05.022) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions

Fig. 2 Co-primary endpoints evaluated (0–100mm VAS) over 12-week period of treatment with placebo, etoricoxib 30mg/day, or ibuprofen 2400mg/day in patients with OA of the knee or hip. (a) WOMAC-PS; (b) WOMAC-PFS; (c) PGADS; and (d) pairwise treatment differences (VAS) in co-primary endpoints for patients with OA treated daily with etoricoxib 30mg, ibuprofen 2400mg, or placebo. Note: the week number for each group has been shifted along the horizontal scale to improve legibility. Error bars are standard errors. S=screening and R=randomization. Osteoarthritis and Cartilage 2007 15, 1348-1356DOI: (10.1016/j.joca.2007.05.022) Copyright © 2007 Osteoarthritis Research Society International Terms and Conditions